FDA To Rethink Pre-Market Approval Process For Radiotherapy Devices
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to reduce dosage errors and misaligned exposures during therapeutic radiation by rethinking pre-market approval strategies for certain radiation therapy devices
You may also be interested in...
New Guidance Will Clarify Which Devices Aren't Eligible For Simpler 510(k)s
Firms that say they've had a harder time getting "special" 510(k) submissions cleared by FDA may benefit from clarifications expected in upcoming agency guidance.
New Guidance Will Clarify Which Devices Aren't Eligible For Simpler 510(k)s
Firms that say they've had a harder time getting "special" 510(k) submissions cleared by FDA may benefit from clarifications expected in upcoming agency guidance.
Industry Unveils Radiation Therapy Patient Protection Effort At FDA Meeting
Manufacturers of linear accelerators and other devices for radiation oncology treatments are endorsing an industry "Radiation Therapy Readiness Check Initiative" to help prevent treatment errors